Evidence map›Paper›PMID 32187325›Full record

ArticleMemorias do Instituto Oswaldo Cruz2020

Mapping the tuberculosis scientific landscape among BRICS countries: a bibliometric and network analysis.

Kamaiaji Castor, Fabio Batista Mota, Roseli Monteiro da Silva, Bernardo Pereira Cabral, Ethel Leonor Maciel, Isabela Neves de Almeida, Denise Arakaki-Sanchez, Kleydson Bonfim Andrade, Vadim Testov, Irina Vasilyeva and 11 more

Open access · diamondAbstract read
In one paragraph

Article in Memorias do Instituto Oswaldo Cruz, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 12 institutions in 7 countries.

Kamaiaji CastorFundação Oswaldo Cruz-Fiocruz, Centro de Estudos Estratégicos, Rio de Janeiro, RJ, Brasil.
Fabio Batista MotaFundação Oswaldo Cruz-Fiocruz, Centro de Estudos Estratégicos, Rio de Janeiro, RJ, Brasil.
Roseli Monteiro da SilvaFundação Oswaldo Cruz-Fiocruz, Centro de Estudos Estratégicos, Rio de Janeiro, RJ, Brasil.
Bernardo Pereira CabralFundação Oswaldo Cruz-Fiocruz, Centro de Estudos Estratégicos, Rio de Janeiro, RJ, Brasil.
Ethel Leonor MacielUniversidade Federal do Espírito Santo, Laboratório de Epidemiologia, Vitória, ES, Brasil.
Isabela Neves de AlmeidaUniversidade Federal de Minas Gerais, Faculdade de Medicina, Laboratório de Pesquisa em Micobactérias, Belo Horizonte, MG, Brasil.ORCID http://orcid.org/0000-0001-6152-7648
Denise Arakaki-SanchezMinistério da Saúde, Programa Nacional de Controle da Tuberculose, Brasília, DF, Brasil.
Kleydson Bonfim AndradeMinistério da Saúde, Programa Nacional de Controle da Tuberculose, Brasília, DF, Brasil.
Vadim TestovNational Medical Research Centre of Pthtisiopulmonology and Infection Diseases, MoH, Moscow, Russian Federation.
Irina VasilyevaNational Medical Research Centre of Pthtisiopulmonology and Infection Diseases, MoH, Moscow, Russian Federation.
Yanlin ZhaoNational Centre for Tuberculosis Control and Prevention, China CDC, Changping District, Beijing, China.
Hui ZhangNational Centre for Tuberculosis Control and Prevention, China CDC, Changping District, Beijing, China.
Manjula SinghIndian Council of Medical Research, New Delhi, India.
Raghuram RaoGovernment of India, Ministry of Health and Family Welfare Central TB Division, New Delhi, India.
Srikanth TripathyNational Institute for Research in Tuberculosis, Chennai, India.
Glenda GrayUniversity of KwaZulu-Natal, Doris Duke Medical Research Institute, South African Medical Research Council HIV-TB Pathogenesis and Treatment Research Unit, Congella, South Africa.
Nesri PadayatchiUniversity of KwaZulu-Natal, Doris Duke Medical Research Institute, South African Medical Research Council HIV-TB Pathogenesis and Treatment Research Unit, Congella, South Africa.
Niresh BhagwandinUniversity of KwaZulu-Natal, Doris Duke Medical Research Institute, South African Medical Research Council HIV-TB Pathogenesis and Treatment Research Unit, Congella, South Africa.
Soumya SwaminathanPhthisiology, Central TB Research Institute, Moscow, Russian Federation.
Tereza KasaevaPhthisiology, Central TB Research Institute, Moscow, Russian Federation.
Afrânio KritskiUniversidade Federal do Rio de Janeiro, Faculdade de Medicina, Programa Acadêmico de Tuberculose, Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz · BRSouth African Medical Research Council · ZAChinese Center For Disease Control and Prevention · CNMinistério da Saúde · BRUral research Institute of Phthisiopulmonology · RUWorld Health Organization · CHGovernment of India · INIndian Council of Medical Research · INNational Tuberculosis Institute · INUniversidade Federal de Minas Gerais · BRUniversidade Federal do Espírito Santo · BRUniversidade Federal do Rio de Janeiro · BR

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundThe five BRICS (Brazil, Russian, Indian, China, and South Africa) countries bear 49% of the world's tuberculosis (TB) burden and they are committed to ending tuberculosis.

objectivesThe aim of this paper is to map the scientific landscape related to TB research in BRICS countries.

methodsWere combined bibliometrics and social network analysis techniques to map the scientific publications related to TB produced by the BRICS. Was made a descriptive statistical data covering the full period of analysis (1993-2016) and the research networks were made for 2007-2016 (8,366 records). The bubble charts were generated by VantagePoint and the networks by the Gephi 0.9.1 software (Gephi Consortium 2010) from co-occurrence matrices produced in VantagePoint. The Fruchterman-Reingold algorithm provided the networks' layout.

findingsDuring the period 1993-2016, there were 38,315 peer-reviewed, among them, there were 11,018 (28.7%) articles related by one or more authors in a BRICS: India 38.7%; China 23.8%; South Africa 21.1%; Brazil 13.0%; and Russia 4.5% (The total was greater than 100% because our criterion was all papers with at least one author in a BRICS). Among the BRICS, there was greater interaction between India and South Africa and organisations in India and China had the highest productivity; however, South African organisations had more interaction with countries outside the BRICS. Publications by and about BRICS generally covered all research areas, especially those in India and China covered all research areas, although Brazil and South Africa prioritised infectious diseases, microbiology, and the respiratory system. MAIN

conclusionsAn overview of BRICS scientific publications and interactions highlighted the necessity to develop a BRICS TB research plan to increase efforts and funding to ensure that basic science research successfully translates into products and policies to help end the TB epidemic.

Indexed as

BibliometricsPublication BiasTuberculosisBiomedical ResearchBrazilChinaHumansIndiaPeriodicals as TopicRussiaSouth Africa

Identifiers

PMID32187325
PMCPMC7066990
OpenAlexW3011132605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.